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Abstract 
The adverse effects of micro pollutant residues in water on the environment and human health could take place under 
a very low concentration range; from several μg L-1 to ng L-1. Since there is no efficient unit process to remove these 
pollutants, efficient technologies are sought to treat them. Ferrate (VI) exhibits high oxidation/reduction potentials 
and has many advantages because of its dual functions of oxidation and coagulation. Removal of micro pollutants by 
ferrate(VI) was pH dependant and this was in coordinate to the chemical/physical properties of the pollutants and 
ferrate(VI) speciation. Promising performance of ferrate(VI) in the treatment of real waste water was observed. It is 
important to determine whether the ferrate(VI) treated water contains any toxic or mutagenic substances as this 
should relieve public health concerns when a new chemical is employed for water treatment. The toxicity studies on 
the ferrate(VI) treated effluent were carried out initially via Ames tests and recently via zebrafish embryos tests 
conducted at . These results suggest that ferrate(VI) reagents do not produce mutagenic by-products for 
study conditions. However, a recent other study showed the formation of adsorbable organic haloids (AOX) as by-
products in the ferrate(VI) treated waste water effluents. Obviously, more researches are needed to investigate the 
formation potential of harmful by-products during ferrate(VI) treatment. Other future work are suggested in order to 
implement ferrate(VI) into full-scale water treatment and other environmental remediation requirements. 
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1. Emerging micro-pollutants in water and wastewater 
Pharmaceutical and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) are 
classified as emerging micro-pollutants, which have been a significant issue of environmental and public 
health concern because they may be significant adverse environmental and human health effects although 
the occurrence of these pollutants in the environment is usually in a very low concentration range; from 
-1 to ng L-1.  
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Pharmaceuticals such as antibiotics, anti- -blockers and X-ray contrast media are 
widely used, these pharmaceuticals and their metabolites cannot be fully utilized by human beings or 
animals and are inevitably emitted into the waters by execration [1-4] and/or through the discharge of 
industry effluents and hospitals waste waters [5, 6]. Results of toxicology studies have revealed that some 
pharmaceuticals are suspected to have direct toxicity to certain aquatic organisms [7-9] and they could 
accumulate slowly, and finally lead to irreversible change on wildlife and human beings [10]. The adverse 
environmental and human health effects could take place under a very low concentration range; from 
several μg L-1 to ng L-1.  
Endocrine disrupting chemicals (EDCs) are defined as the natural and/or synthetic compounds which 
would affect endocrine systems of fishes and other aqueous animals. Since the middle of last decade, a 
variety of adverse effects of EDCs on the endocrine systems of animals have been observed [11, 12]. 
These effects may be cumulative, possibly will only appear in subsequent generations, and then the 
resulting effects may be irreversible, threat
synthetic organic chemicals being introduced to the environment by anthropogenic inputs, (e.g., bisphenol 
A) but they can also be naturally generated estrogenic hormones, e.g., estrone (E1) and 17 -estradiol (E2), 
and therefore are ubiquitous in aquatic environments receiving wastewater effluents. 
Personal care products (PCPs) represent a large group of compounds which include non-prescription 
and prescription pharmaceuticals for human and veterinary use, and the active and inert ingredients for 
personal care purposes. Examples of PCPs include analgesics, lipid regulators, synthetic hormones, 
steroids, fragrances, sun screens, shampoos and cosmetics. Most PCPs, in their original or biologically 
altered form, are discharged into wastewater and make their way to wastewater treatment plants. Possible 
fates of PCPs and their metabolites within a wastewater treatment plants are: 1) mineralization to CO2 
and water; 2) retention to the solids portion (sludge/biosolids) if the compound entering the plant or the 
product of biologically mediated transformation is lipophilic; 3) release to the receiving water either as 
the original compound or as a degradation product.  
The presence of emerging micro pollutants and their potential toxicity are challenge to the global water 
industries as there is no unit process specifically designed to remove these pollutants; activated sludge 
and secondary sedimentation in most wastewater treatment works (WWTWs) seems to be inefficient to 
eliminate them [13-17]. Thus, a number of recent studies have been carried out to explore suitable 
technologies to treat pharmaceutical residuals from water and wastewater. Ozonation was found to be 
effective to remove pharmaceuticals in municipal WWTWs [18]. Nanofiltration (NF) and reverse osmosis 
(RO) membrane filtration have been applied at bench, pilot and full scale [19]. Activated carbon 
adsorption [20] has also been proved as an efficient process to remove pharmaceuticals; addition of 5 mg 
L-1 of powder activated carbon with a 4-h contact time removed 50% to >98% of the volatile PPCPs and 
10% to >95% of the polar PPCPs [21]. 
2. Ferrate(VI) and its application in water and wastewater treatment and in degradation of 
emerging micro pollutants 
A promising technique which can address the concerns on emerging micro pollutants is ferrate (VI) 
which exhibits many advantages because of its dual functions for the oxidation and coagulation [22-26] 
and it has green chemical properties [27]. Ferrate(VI) has been successfully applied into water 
remediation processes [28-32] and to the oxidation of carbohydrates [33] and nitrogen-containing 
pollutants [34]. The removal of pharmaceuticals and other micro pollutants by ferrate(VI) have been 
extensively studied [35-40]. 
2.1. General water and waste water treatment by ferrate(VI) 
Ferrate(VI) can act as coagulant, disinfectant and oxidant. An early study conducted by the author [24] 
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demonstrated in comparison with ferric sulfate (FS), ferrate(VI) can achieve high organic matter removal 
as DOC (see Fig. 1). 
 
Fig.1. Removal of DOC for drinking water treatment with various ferrate dosage compared with ferric sulfate [24]. 
 
In a study [31] using ferrate(VI) for raw sewage treatment, much smaller dose of ferrate(VI) was 
required, in comparison with ferric sulfate (FS, Fe3+), to efficiently remove suspended solids (SS), 
chemical oxygen demand (COD), biochemical oxygen demand (BOD) and phosphorous (P). Dashed lines 
in Fig. 2 are low and upper limits of the required percentage removal for controlling quality parameters in 
post-sedimentation. The removal efficiency of SS, COD, BOD and P exceeded the high requirement by 
ferrate(VI) at lower doses. 
 
 
Fig.2. Comparison Fe6+ with Fe3+ for (a) SS, (b) COD, (c) BOD and (d) P% removal [31]. 
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Ferrate(VI) is efficient in inactivating Eschericha coli, total coliforms and f2 coliphage viruses [41]. 
Fig. 3 shows significant fast rates of E. coli inactivation by ferrate(VI) with smaller Ct values required to 
achieve 4 Log inactivation at a low dose, 1.5 mg L-1 and in neutral pH range, 6.8  7.2 [42]. 
Ferrate(VI) has been used as an oxidant in conjunction with coagulation for algal removal [43]. The 
combined use of ferrate(VI) ands alum, algal removal increased significantly in comparison with that 
using alum alone (Fig. 4). 
 
                 
 
Fig. 3. Inactivation level of E. coli (log(N/N0) and exposure amount        Fig.4. Effect of ferrate(VI) oxidation on the removal of 
of E. coli to Fe(VI) at various pH values [42].                                           algae by alum [43]. 
 
Although potentials of ferrate(VI) to act as coagulant, disinfectant and oxidant for water and waste 
water treatment have been widely investigated, researches will still be required to assess treatment 
efficiency and cost effectiveness considering simultaneously removing turbidity, dissolved organic carbon, 
particles and lowering residual iron, microbial activity in drinking water treatment and the removal of SS, 
COD, BOD, phosphorous and micro pollutants  in waste water treatment. 
The ferrate(VI) efficiency to remove 68 selected endocrine disrupting chemicals (EDCs) and 
pharmaceuticals and personal care products (PPCPs) spiked in a waste water matrix were studied in two 
wastewater treatment plants (WWTPs) [37]. Thirty-one target EDCs and PPCPs were detected in the 
effluents of the two WWTPs with concentrations ranging from 0.2 to 1156 ng L-1. Ferrate (VI) treatment 
resulted in selective oxidation of electron rich organic moieties of these target compounds, such as phenol, 
olefin, amine and aniline moieties. But Ferrate (VI) failed to react with triclocarban, 3 androgens, 7 acidic 
pharmaceuticals, 2 neutral pharmaceuticals and erythromycin-H2O. 
 pharmaceuticals were spiked into the effluent samples 
-1 for each compound. Results showed that removal efficiencies of 
ciprofloxacin and naproxen were up to 70% and 50%, respectively, for ferrate(VI) doses up to 5 mg L-1. 
Except ciprofloxacin and naproxen, raising ferrate(VI) dose did not improve the removal of other 
pharmaceutical significantly (Fig. 5). The relative high reactivity of ciprofloxacin and naproxen with 
Fe(VI) may be attributed to electron donation by the methoxy group to the naphthalene moiety [37, 44]. 
The acidic pharmaceuticals compounds (such as ibuprofen) showed less reactivity with ferrate(VI) 
because a carboxylic group is an electron-withdrawing functional group, which can depress the reaction 
of aromatic ring with Fe(VI). Therefore, the reactivity of Fe(VI) with carboxylic acids is usually slow. 
The rate constant for the reaction of ferrate(VI) with selected EDCs and PPCPs can be seen in Table 1. 
The data indicate relative reaction activities between ferrate(VI) and various compounds. Ferrate(VI) can 
degrade most listed EDCs at rapid speed except for Buten-3-ol which has low reactivity with ferrate(VI). 
For the PPCPs, atenolol, carbamazepine, ibuprofen have low reactivity especially ibuprofen has the 
slowest reaction rate with ferrate(VI). On the other hand, the relative high reactivity of most EDCs and 
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PPCPs with ferrate(VI) may be attributed to electron donation by the specific group to the naphthalene 
moiety [37, 44].  
 
Table 1. Second order rate constants k, M-1s-1 for the reaction of ferrate(VI) with selected endocrine disrupting chemicals (EDCs) 



















17 -Ethinylestradiol  7 7.3 × 10
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â-estradiol  7 7.7 × 10
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Atenolol 8 7   [46] 
Bisulfite 8 1.90 × 10
4  0.7 s  
 
[47] Bisulfite 7 8.24 × 10
4  0.2 s 
Carbamazepine 8 16   [44] 
Ciprofloxacin  7 4.7 × 102  29.4 s   
[45] Enrofloxacin  7 4.6 × 101  300 s  
Ethionine 8 8.3 × 10
2  17 s [47] 
Glycolic acid  8 4.0 × 10-1  1.39 h  [48] 
Glycolic acid  12.4 7.2 × 102   [27] 
Glycylglycine  7 8.2 × 102  17 s  [49] 
Ibuprofen 8 0.4   [46] 
Iodide 7 6.67 × 10
3  2.1 s 
 
[47] Iodide 8 1.54× 10
3  9.0 s  
Sulfamethizole  7 4.1 × 102  33.9 s  [50] 
Sulfamethoxazole 8 95   [44] 
Sulfamethoxazole  7 1.3 × 103  10.4 s  
[50] 
Sulfisoxazole  7 1.5 × 103  9.2 s  
 
 




























Fig. 5. Pharmaceuticals removal by ferrate(VI) at pH 6. 
3. Assessment of the toxicity of ferrate(VI) treated water and waste water 
It is important to determine whether the ferrate(VI) treated water contains any toxic or mutagenic 
substances as this should relieve public health concerns when a new chemical is employed for water 
treatment. The Ames test has been applied to ferrate(VI) treated water and a preliminary study 
demonstrated negative results [51], suggesting that ferrate(VI) reagents do not produce mutagenic by-
products for the st
toxicity of the ferrate(VI) treated waste water effluent was assessed and compared with that of raw waste 
water effluent by the zebrafish embryos model. The zebrafish, a small tropical fish native to the rivers of 
India and South Asia [52], has become one of the most popular model organisms in developmental 
genetics and (eco) toxicology [53-55]. The zebrafish embryos represent an attractive model for 
environmental risk assessment of chemicals since they offer the possibility to perform small-scale, high-
throughput analyses. The results of both mortality of zebrafish embryo tests and microscopic images 
demonstrated that raw waste water effluents possessed toxicity to zebrafish but ferrate (VI) treated 
effluents had no adverse effects. 
As shown in Table 2, a number of other studies have reported the potential formation of harmful by 
products. Most recently, A study showed the formation of adsorbable organic haloids (AOX) as by-
products in the ferrate(VI) treated waste water effluents although the AOX concentration rise was lower 
than that in the chlorination process [56].  
Obviously, more researches need carried out to investigate the formation potential of harmful by-
products during ferrate(VI) treatment. For example, it is to be studied under which operating conditions 
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Table 2. Harmful by products formation in the  ferrate(VI) treated waste water 
Compound By-product Ref.  
Carbohydrates Aldehydes [57] 
Aniline Azobenzene and Nitrobenzene [58] 
Phenol Pbenzoquninone and Biphenols [58] 
Methanol Formaldehyde [59-61] 
Carbamazepine Aldehyde, Ketone, and Carboxyl groups [62] 
Sulfamethoxazole Methyl group compounds [50] 
Trimethoprim 3,4,5,-trimethoxybenzaldehyde and 2,4-dinitropyrimidine [63] 
 
4. Concluding remarks - feasibility of ferrate(VI) treatment in full scale water and waste water 
treatment 
The high oxidation properties of ferrate(VI) were discovered a long time ago but systematic studies of 
oxidising a number of organic compounds or pollutants using ferrate(VI) can be dated back to the early 
1970s. Oxidation of micro pollutants existing in water and waste water by ferrate(VI) has been studied 
extensively since the beginning of this century. The advances in analytical chemistry theory and 
instrument allow tiny and low level concentrations of micro-pollutants could be detected which helps the 
new legislated regulations could be setup and quality of water could be monitored. Water industries have 
to meet the requirement of stringent water and waste water quality regulations and therefore, alternative 
technologies are sought by water industries.  
A number of laboratory based studies have investigated schemes and mechanisms, possible by-
products formation, and kinetics or rate constants of the degradation of micro pollutants; these have 
advanced knowledge of the use of ferrate(VI) for the environmental remediation. In comparison with 
these fundamental studies, relative smaller number researchers have focused on the practical application 
of ferrate(VI) for water and waste water treatment or the environmental remediation such as odour 
removal and sewage sludge treatment. Nevertheless, a few of cases have been reported that ferrate(VI) 
have been used in full scale applications so far. 
Studies on the overall efficiency of ferrate(VI) as a coagulant, an oxidant or a disinfectant have been 
carried out for water and waste water treatment. However, there are some fundamental issues which have 
not yet been studied thoroughly and are critical to implement ferrate(VI) into full-scale water treatment 
and other environmental remediations. This author suggests following future work to be carried out: 
(1) To classify and assess the toxicity of the potential degraded by-products when ferrate(VI) is used 
to oxidise various micro-pollutants; 
(2) To study the effects of dosing points, dosing methods, dosing farcicalities and mixing schemes on 
the ferrate(VI) performance in water and wastewater treatment; 
(3) To investigate the impact of water quality characteristics on the ferrate(VI) efficiency as a 
disinfectant and as an oxidant; 
(4) To assess the effect of ferrate(VI) dose and pH on the reduction of various micro-pollutants and on 
the inactivation of bacteria and virus in sewage sludge treatment, and finally; 
(5) To carry out a full-scale trial to validate the treatment performance obtained in the laboratory 
studies and to evaluate economic suitability of using ferrate(VI) comprehensively. 
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